The filing

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Acquisition of Oriflame India's Manufacturing Business

Company

Akums Drugs and Pharmaceuticals Ltd · BSE 544222

Filed

23 July 2026, 23:19 IST

BSE category

Company Update / Acquisition

Tag

Acquisition · selected

Source

Open the filing on BSE →

Why it led

• First Acquisition from this company — not seen in the 68 trading days on record
• Small cap

Selected by the ranker from 46 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

523 of 83,122 filings in the published window carry Acquisition · 0.63%

Around it

Most recent filings from Akums Drugs and Pharmaceuticals Ltd

• ESG Rating General 3 September 2026
• Analyst / Investor Meet - Intimation Analyst / Investor Meet 25 August 2026
• Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026 General 24 August 2026